NPM1 and acute myeloid leukemia: These results are in agreement with a previous retrospective study that analyzed 156 patients with NPM1‐mutated AML without FLT3‐ITD, which demonstrated that both CR2 and advanced disease at transplant, negatively affected RI (HR 3.65 p = 0.02 and HR 5.73 p = 0.0002, respectively), LFS (HR 2.53 p = 0.005 and HR 3.94 p = 0.0002, respectively), and OS (HR 2.30 p = 0.02 and HR 3.90 p = 0.01, respectively).10